Variation in AKR1C3, which encodes the neuroactive steroid synthetic enzyme 3α-HSD type 2 (17β-HSD type 5), moderates the subjective effects of alcohol

被引：0
|
作者：
Verica Milivojevic
Richard Feinn
Henry R. Kranzler
Jonathan Covault
机构：
[1] University of Connecticut School of Medicine,Alcohol Research Center, Department of Psychiatry
[2] Quinnipiac University,Department of Medical Sciences, Frank Netter School of Medicine
[3] University of Pennsylvania Perelman School of Medicine,Department of Psychiatry
[4] Philadelphia VAMC,VISN4 MIRECC
[5] University of Connecticut Health Center,Department of Neuroscience
来源：
Psychopharmacology | 2014年 / 231卷
关键词：
Psychiatric Genetics; 3α-HSD; 17β-HSD; Alcohol dependence; Polymorphism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3597 / 3608
页数：11
相关论文
共 50 条
  • [1] Variation in AKR1C3, which encodes the neuroactive steroid synthetic enzyme 3α-HSD type 2 (17β-HSD type 5), moderates the subjective effects of alcohol
    Milivojevic, Verica
    Feinn, Richard
    Kranzler, Henry R.
    Covault, Jonathan
    PSYCHOPHARMACOLOGY, 2014, 231 (17) : 3597 - 3608
  • [2] VARIATION IN THE NEUROACTIVE STEROID SYNTHETIC ENZYME 3α-REDUCTASE TYPE 2 MODERATES SUBJECTIVE EFFECTS OF ALCOHOL
    Milivojevic, V.
    Kranzler, H. R.
    Covault, J.
    ALCOHOL AND ALCOHOLISM, 2011, 46 : 38 - 38
  • [3] VARIATION IN GENES ENCODING THE NEUROACTIVE STEROID SYNTHETIC ENZYMES 5A-REDUCTASE TYPE 1 AND 3A-HSD TYPE 2 IS ASSOCIATED WITH ALCOHOL DEPENDENCE
    Milivojevic, V.
    Kranzler, H. R.
    Burian, L.
    Covault, J.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (06) : 72A - 72A
  • [4] Type 2 3a/Type 5 17β-HSD (AKR1C3) Is a Negative Regulator of Breast Cancer Proliferation: An Immunohistochemical and In Vitro Study
    Murugan, P.
    Lin, H-K
    Wu, W.
    Miller, V.
    Yang, Q.
    Fung, K-M
    MODERN PATHOLOGY, 2012, 25 : 55A - 55A
  • [5] Type 2 3a/Type 5 17β-HSD (AKR1C3) Is a Negative Regulator of Breast Cancer Proliferation: An Immunohistochemical and In Vitro Study
    Murugan, P.
    Lin, H-K
    Wu, W.
    Miller, V.
    Yang, Q.
    Fung, K-M
    LABORATORY INVESTIGATION, 2012, 92 : 55A - 55A
  • [6] Cinnamic acids as new inhibitors of 17β-hydroxy steroid dehydrogenase type 5 (AKR1C3)
    Brozic, P
    Golob, B
    Gomboc, N
    Rizner, TL
    Gobec, S
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 248 (1-2) : 233 - 235
  • [7] In vitro and in vivo characterisation of ASP9521: a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid dehydrogenase type 5 (17βHSD5; AKR1C3)
    Aya Kikuchi
    Takashi Furutani
    Hidenori Azami
    Kazushi Watanabe
    Tatsuya Niimi
    Yoshiteru Kamiyama
    Sadao Kuromitsu
    Edwina Baskin-Bey
    Marten Heeringa
    Taoufik Ouatas
    Kentaro Enjo
    Investigational New Drugs, 2014, 32 : 860 - 870
  • [8] In vitro and in vivo characterisation of ASP9521: a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid dehydrogenase type 5 (17βHSD5; AKR1C3)
    Kikuchi, Aya
    Furutani, Takashi
    Azami, Hidenori
    Watanabe, Kazushi
    Niimi, Tatsuya
    Kamiyama, Yoshiteru
    Kuromitsu, Sadao
    Baskin-Bey, Edwina
    Heeringa, Marten
    Ouatas, Taoufik
    Enjo, Kentaro
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (05) : 860 - 870
  • [9] Variation in Genes Encoding the Neuroactive Steroid Synthetic Enzymes 5α-Reductase Type 1 and 3α-Reductase Type 2 Is Associated With Alcohol Dependence
    Milivojevic, Verica
    Kranzler, Henry R.
    Gelernter, Joel
    Burian, Linda
    Covault, Jonathan
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2011, 35 (05) : 946 - 952
  • [10] Suppressed expression of type 2 3α/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) in endometrial hyperplasia and carcinoma
    Zakharov, Vladislav
    Lin, Hsueh-Kung
    Azzarello, Joseph
    McMeekin, Scott
    Moore, Kathleen N.
    Penning, Trevor M.
    Fung, Kar-Ming
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2010, 3 (06): : 608 - 617
12345